• 1
    Talley NJ. Irritable bowel syndrome; definitions, diagnosis and epidemiology. Bailllieres Best Pract Res Clin Gastroenterol 1999; 13: 37184.
  • 2
    Quigley EM. Why do we have so few effective drugs for IBS? A European perspective. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 4367.
  • 3
    Nahin RL, Pontzer CH, Chesney MA. Racing toward the integration of complementary and alternative medicine: a marathon or a sprint? Health Aff 2005; 24: 9913.
  • 4
    National Center for Complementary and Alternative Medicine. Available at: Last accessed 12 December 2005.
  • 5
    Myers C, Jacobsen P Integrative medicine and oncology: emerging evidence. Cancer Control 2005; 12: 1467.
  • 6
    Sun X, Cai G, Wang WG. Observation on intestinal flora in patients of IBS after treatment of Chinese integrative medicine. Zhong Xi Yi Jie He Xue Bao 2004; 2: 3402.
  • 7
    Eisenberg DM, David RB, Ettner SL, et al. Trends in alternative medicine use in United States, 1990–1997; results of a follow up national survey. JAMA 1998; 280: 156975.
  • 8
    Eisenberg DM, Kessler RC, Van Rompay MI, et al. Perceptions about complementary therapies relative to conventional therapies. Ann Intern Med 2001; 135: 34451.
  • 9
    Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA 1998; 280: 15859.
  • 10
    Koretz RL, Rotblatt M. Complementary and alternative medicine in gastroenterology: the good, the bad, and the ugly. Clin Gastroenterol Hepatol 2004; 2: 95767.
  • 11
    Bloom BS, Retbi A, Dahan S, Jonsson E. Evaluation of randomized controlled trials on complementary and alternative medicine. Int J Technol Assess Health Care 2000; 16: 1321.
  • 12
    Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998; 19: 15966.
  • 13
    Kong SC, Hurlstone DP, Pocock CY, Walkington LA. The incidence of self prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol 2005; 39: 13841.
  • 14
    Koloski NA, Talley NJ, Huskie SS, Boyce PM. Predictors of conventional and alternative health care seeking for irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17: 84151.
  • 15
    Patel SM, Stason W, Legedza A, et al. The placebo effect in irritable syndrome trials: a meta-analysis. Neurogastroenterol Motil 2005; 17: 33240.
  • 16
    Pitz M, Cheang M, Bernstein CN. Defining the predictors of the placebo response in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005; 3: 23747.
  • 17
    Tovey P. A single-blind trail of reflexology for irritable bowel syndrome. Br J Gen Pract 2002; 52: 1923.
  • 18
    Keefer L, Blanchard EB. Effects of relaxation response mediation on the symptoms of IBS: results of a controlled treatment study. Behav Res Ther 2001; 39: 80111.
  • 19
    Keefer L, Blanchard EB. One year follow up of relaxation response meditation as a treatment for IBS. Behav Res Ther 2002; 40: 5416.
  • 20
    Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol 2002; 97: 95461.
    Direct Link:
  • 21
    Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive changes in patients undergoing hypnotherapy for IBS. J Psychosom Res 2004; 57: 2718.
  • 22
    Tan G, Hammond DC, Joseph G. Hypnosis and IBS: a review of efficacy and mechanism of action. Am J Clin Hypn 2005; 43: 16178.
  • 23
    Langmead L, Chitnis M, Rampton DS. Use of complementary therapies by patients in IBD may indicate psychosocial distress. Inflamm Bowel Dis 2002; 8: 1749.
  • 24
    Friedman G. Treatment of the irritable bowel syndrome. Gastroenterol Clin North Am 1991; 20: 32533.
  • 25
    Kline RM, Kline JJ, Di Palma J, Barbero GJ. Enteric-coated, pH-dependent peppermint oil capsule for the treatment of irritable bowel syndrome in children. J Pediatr 2001; 138: 1258.
  • 26
    May B, Kohler S, Schneider B. Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia. Aliment Pharmacol Ther 2000; 14: 16717.
  • 27
    Liu JH, Chen GH, Yeh HZ, Haung CK, Poon SK. Enteric-coated peppermint oil capsule in the treatment of irritable bowel syndrome, a prospective randomized trail. J Gastroenterol 1997; 32: 7658.
  • 28
    Dew MJ, Evans BK, Rhodes J. Peppermint oil for irritable bowel syndrome, a multicentre trial. Br J Clin Pract 1984; 38: 3948.
  • 29
    Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical view and meta-analysis. Am J Gastroenterol 1998; 93: 11315.
    Direct Link:
  • 30
    Spanier JA, Howden CW, Jones MP. A systematic review of alternative medicine therapies in the irritable bowel syndrome. Arch Intern Med 2003; 163: 26574.
  • 31
    Zar S, Mincher L, Benson MJ, Kumar D. Food specific IgG4 antibodies guided exclusion diet improves symptoms and rectal compliance in IBS. Scand J Gastroenterol 2005; 40: 8007.
  • 32
    Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in IBS: a randomised controlled trial. Gut 2004; 53: 145964.
  • 33
    Quigley EM. The use of probiotics in functional bowel disease. Gastroenterol Clin North Am 2005; 34: 53345.
  • 34
    King TS, Elia M, Hunter JO. Abnormal colonic fermentation in the irritable bowel syndrome. Lancet 1998; 352: 11879.
  • 35
    Nobaek S, Johanson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 12318.
    Direct Link:
  • 36
    Kim HJ, Camilleri M, McKenzie S, Lempke MB, Burton DD. A randomized controlled trail of a probiotic, VSL#3 on gut transit and symptoms in diarrhoea-predominant IBS. Aliment Pharmacol Ther 2003; 17: 895904.
  • 37
    Kim HJ, Vazquez Roque MI, Camilleri M, et al. A randomised controlled trial of probiotic combination VSL#3 and placebo in IBS with bloating. Neurogastroenterol Motil 2005; 17: 68796.
  • 38
    O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128: 54151.
  • 39
    Chan J, Carr I, Mayberry JF. The role of acupuncture in the treatment of irritable bowel syndrome; a pilot study. Hepatogastroenterology 1997; 44: 132830.
  • 40
    Forbes A, Jackson S, Walter C, Queraishi S, Jacyna M, Pitcher M. Acupuncture for irritable bowel syndrome, a double-blind placebo-controlled trial. World J Gastroenterol 2005; 11: 40404.
  • 41
    Vozeh A. Is the increasing use of evidence-based pharmacotherapy causing the renaissance of complementary medicine? Br J Clin Pharmacol 2003; 56: 2926.